# Case Report: Dual pathogenic mechanism of a PRKG2 missense variant underlies an attenuated phenotype of acromesomelic dysplasia

**Authors:** Daria Akimova, Tatiana Markova, Maria Orlova, Vladimir Kenis, Mikhail Skoblov

PMC · DOI: 10.3389/fgene.2025.1708985 · Frontiers in Genetics · 2026-01-08

## TL;DR

A girl with a rare bone disorder had a milder condition due to two genetic changes in the PRKG2 gene that caused partial, not complete, loss of protein function.

## Contribution

The study reveals a dual pathogenic mechanism of a PRKG2 missense variant leading to an attenuated acromesomelic dysplasia phenotype.

## Key findings

- Two novel PRKG2 variants were identified in a patient with acromesomelic dysplasia.
- The missense variant created a cryptic splice site, producing two abnormal protein products.
- The combined effects caused partial loss of function, explaining the milder clinical features.

## Abstract

Acromesomelic dysplasia comprises a group of rare skeletal disorders characterized by dwarfism with anomalies predominantly affecting the middle and distal segments of the limbs. Based on genetic variants, five types are recognized, with significant phenotypic variability even within a single type. Here, we describe a girl presenting with borderline short stature and mild disproportion due to acro- and mesomelic shortening of the limbs. Radiographic examination revealed shortening of the radius and ulna, mild brachydactyly, absence of iliac flaring and metaphyseal alterations of the long bones, and biconcave appearance of the femoral necks and II-IV metacarpals, and an elongated styloid process of the ulna. Using WGS, we identified two novel variants in the PRKG2 gene: a frameshift variant (NM_006259.3:c.1074del (p.Ala359LeufsTer24)) and a missense variant (NM_006259.3:c.1630G>T (p.Asp544Tyr)). Functional analysis unveiled a unique dual pathogenic mechanism: the missense variant creates a cryptic splice site, resulting in two aberrant protein products - an in-frame deletion and a missense substitution. We hypothesize that these alterations cause a partial, rather than a complete, loss of protein function, which may account for the patient’s attenuated clinical phenotype.

## Linked entities

- **Genes:** PRKG2 (protein kinase cGMP-dependent 2) [NCBI Gene 5593]
- **Diseases:** acromesomelic dysplasia (MONDO:0019696)

## Full-text entities

- **Genes:** PRKG2 (protein kinase cGMP-dependent 2) [NCBI Gene 5593] {aka AMD4, PKG2, PRKGR2, SMDP, cGK2, cGKII}
- **Diseases:** short stature (MESH:D006130), acro- and mesomelic shortening (MESH:C565404), brachydactyly (MESH:D059327), dwarfism (MESH:D004392), Acromesomelic dysplasia (MESH:C535658), skeletal disorders (MESH:C564967)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.1074del, p.Asp544Tyr, c.1630G>T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12823036/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12823036/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12823036/full.md

---
Source: https://tomesphere.com/paper/PMC12823036